Search Results - "Anoshenkova, O N"

Are the Goals of Therapy Achievable in Patients with Rheumatoid Arthritis Receiving Upadacitinib in Real Clinical Practice? by Amirdzhanova, V. N., Karateev, A. E., Pogozheva, E. Yu, Filatova, E. S., Samigullina, R. R., Mazurov, V. I., Anoshenkova, O. N., Lapkina, N. A., Baranov, A. A., Grineva, T. Yu, Lila, A. M., Nasonov, E. L.

“…The aim of the study was to evaluate the effectiveness of UPA in RA patients in real clinical practice after 3 and 6 months of therapy. The study included 63…”
Get full text

Erratum to: Are the Goals of Therapy Achievable in Patients with Rheumatoid Arthritis Receiving Upadacitinib in Real Clinical Practice? by Amirdzhanova, V. N., Karateev, A. E., Pogozheva, E. Yu, Filatova, E. S., Samigullina, R. R., Mazurov, V. I., Anoshenkova, O. N., Lapkina, N. A., Baranov, A. A., Grineva, T. Yu, Lila, A. M., Nasonov, E. L.

“…An Erratum to this paper has been published: https://doi.org/10.1134/S1607672923050010…”
Get full text

Real-World Retention Rate, Effectiveness, and Safety of Netakimab in the Treatment of Patients with Ankylosing Spondylitis: First Year Results of the LIBRA Post-Registration Safety Study by Erdes, Sh, Mazurov, V. I., Gaydukova, I. Z., Anoshenkova, O. N., Vinogradova, I. B., Grabovetskaya, Yu. Yu, Davidian, S. Y., Kiryukhina, N. A., Epifanova, O. E., Masneva, L. V., Menshikova, L. V., Mironenko, O. N., Nikulenkova, N. E., Povarova, T. V., Poliatika, A. N., Samigullina, R. R., Sizikov, A. E., Totrov, I. N., Umnova, I. F., Usacheva, J. V., Chudinov, A. L.

“…—Background. Netakimab has shown high efficacy in controlled clinical trials in the treatment of AS patients. This article presents results of an observational…”
Get full text

Resolution of the Council of Experts of May 20, 2023 "Issues of safety in the treatment of a rheumatological patient" by Alekseeva, L. I., Anoshenkova, O. N., Dolganova, N. G., Zholobova, E. S., Zonova, E. V., Lapshina, S. A., Korolev, M. A., Menshikova, L. V., Shesternya, P. A., Chasovskikh, Yu. P.

“…At the meeting of the Expert Council on May 20, the safety of treatment for patients with osteoarthritis (OA), the most common form of joint disease, was…”
Get full text

Management of patients with rheumatoid arthritis in real clinical practice: Switching from interleukin 6 receptor inhibitors to interleukin 6 inhibitor (olokizumab) by Baranov, A. A., Vinogradova, I. B., Anoshenkova, O. N., Antipova, O. V., Bogdanova, E. A., Grabovetskaya, Y. Y., Ilivanova, E. P., Kalyagin, A. N., Kushnir, I. N., Lapkina, N. A., Mokrousova, M. V., Nesmeyanova, O. B., Nikitina, N. M., Shesternya, P. A., Yudina, N. V., Feist, E., Nasonov, E. L.

“…Aim . Switching to another biologic with the same mode of action provides greater opportunity for long-term management of patients with rheumatoid arthritis…”
Get full text

Real-world retention rate, effectiveness, and safety of netakimab in the treatment of patients with ankylosing spondylitis: First year results of the LIBRA post-registration safety study by Erdes, Sh, Mazurov, V. I., Gaydukova, I. Z., Anoshenkova, O. N., Vinogradova, I. B., Grabovetskaya, Yu. Yu, Davidian, S. Yu, Epifanova, O. E., Kiryukhina, N. A., Masneva, L. V., Menshikova, I. V., Mironenko, O. N., Nikulenkova, N. E., Povarova, T. V., Polyatika, A. N., Samigullina, R. R., Sizikov, A. E., Totrov, I. N., Umnova, I. F., Usacheva, J. V., Chudinov, A. L.

“…Background . Netakimab has shown high efficacy in controlled clinical trials in the treatment of patients with ankylosing spondylitis (AS). This article…”
Get full text

Are the goals of therapy achievable in patients with rheumatoid arthritis receiving upadacitinib in real clinical practice? by Amirjanova, V. N., Karateev, A. E., Pogozheva, E. Yu, Filatova, E. S., Samigullina, R. R., Mazurov, V. I., Anoshenkova, O. N., Lapkina, N. A., Baranov, A. A., Grineva, T. Yu, Lila, A. M., Nasonov, E. L.

“…The aim of the study was to evaluate the effectiveness of UPA in RA patients in real clinical practice after 3 and 6 months of therapy. Material and methods …”
Get full text

Results of a non-interventional multicenter study of management of patients with non-radiological axial spondyloarthritis in real-life clinical practice in the Russian Federation (NiSpAR) by Dubinina, T. V., Lila, A. M., Kvasova, E. V., Agafonova, E. M., Andrianova, I. A., Ivanova, L. V., Yurk, D. V., Garaeva, N.  A., Akulinushkina, E. Y., Vedekhina, A. N., Bashkova, I. B., Lapshina, S. A., Grabovetskaya, Y. Y., Semenova, N. F., Valkova, M. I., Krechikova, D. G., Mazhaeva, O. S., Vinogradova, I. B., Bugrova, O. V., Voloshenko, S. M., Enikeeva, G. R., Immis, E. S., Timasheva, L. F., Biserova, E. E., Shaimukhametova, L. Z., Patrikeeva, I. M., Barakat, A. A., Shesternya, P. A., Nikitina, N. M., Yupatova, M. I., Anoshenkova, O. N., Korolev, M. A., Ubshaeva, Y. B., Vasilenko, E. A., Zonova, E. V., Nesmeyanova, O. B., Bogdanova, E. A., Mazurov, V. I., Samigullina, R. R., Marusenko, I. M.

“…NiSpAR is a non-interventional, multicenter study whose aim was to describe a cohort of patients with non-radiological axial spondyloarthritis (nr-axSpA) and…”
Get full text

The first experience of using upadacitinib in the treatment of rheumatoid arthritis in real clinical practice (results of the multicenter project “RACURS”) by Amirjanova, V. N., Karateev, A. E., Pogozheva, E. Y., Baranov, A. A., Mazurov, V. I., Samigullina, R. R., Anoshenkova, O. N., Lapkina, N. A., Grineva, T. Yu, Nasonov, E. L., Lila, A. M.

“…Upadacitinib (UPA), a JAK inhibitor, is a new therapeutic option that allows patients with insufficient response to therapy with basic anti-inflammatory drugs…”
Get full text

ANALYSIS OF THE RESULTS OF TOFACITINIB THERAPY IN REAL CLINICAL PRACTICE ACCORDING TO THE ALL-RUSSIAN ARTHRITIS REGISTRY (OREL) by Avdeeva, A. S., Misiyuk, A. S., Satybaldyev, A. M., Lukina, G. V., Sorotskaya, V. N., Zhilyaev, E. V., Babaeva, A. R., Baranov, A. A., Mazurov, V. I., Shendrygin, I. N., Salnikova, T. S., Knyazeva, L. A., Krechikova, D. G., Samigullina, R. R., Gaidukova, I. Z., Abdulganieva, D. I., Kushnir, I. N., Anoshenkova, O. N., Lapkina, N. A., Koshkarova, E. A., Lila, A. M., Nasonov, E. L.

“…Objective: to analyze the results of tofacitinib (TOFA) therapy in real clinical practice according to the All-Russian Arthritis Registry (OREL). Subjects and…”
Get full text

Ultraphonophoresis with a hyaluronic acid-containing gel for knee osteoarthritis with periarthritis by Anoshenkova, O. N., Kalyagin, A. N., Maksimova, Yu. V., Sindykheeva, N. G., Sinkov, A. V., Sinkova, G. M.

“…Management of patients with knee osteoarthritis (OA) in the presence of comorbidity causes significant difficulties associated with the limitations of…”
Get full text

HYALURONIC ACID FORMULATIONS IN OSTEOARTHRITIS: POSSIBILITIES FOR IMPORT SUBSTITUTION by Kalyagin, A. N., Anoshenkova, O. N., Antipova, O. V.

“…The paper discusses the possibilities of administering hyaluronic acid in osteoarthritis.  It is noted that the therapeutic efficacy of this drug class has…”
Get full text

Ways to improve the diagnosis and treatment of interstitial lung disease associated with systemic sclerosis in the Siberian Federal District (materials of the advisory board of rheumatologists and pulmonologists from December 08, 2019) by Alekseeva, L. I., Terpigorev, S. A., Zonova, E. V., Kudelya, L. M., Babadaeva, N. M., Teteneva, A. V., Kondrashov, A. A., Orlov, D. N., Raskina, T. V., Anoshenkova, O. N., Chasovskikh, Yu. P., Kropotina, T. V., Opongosheva, A. B., Yudina, N. V., Ganyukova, N. G.

“…The aim of the study was to develop ways to improve the diagnosis and treatment of systemic sclerosis (SSc)-ILD. Interstitial lung disease (ILD) is a common…”
Get full text

The ten-year probability of fractures with the FRAX tool: which threshold for intervention to be used and how? by Lesnyak, O. M., Gladkova, E. N., Ershova, O. B., Skripnikova, I. A., Anoshenkova, O. N., Akhverdyan, Yu. R., Belova, K. Yu, Belousova, I. B., Bolshakova, E. V., Dreval, A. V., Zavodovsky, B. V., Ilyin, M. V., Kosmatova, O. V., Kryukova, L. V., Latfullin, A. A., Leikauskene, E. A., Leonova, N. V., Maksimova, Yu. V., Myagkova, M. A., Novikov, V. E., Nuriev, A. R., Polyakova, E. Yu, Polyakova, Yu. V., Sivordova, L. E., Tavluev, V. A., Shavalieva, L. R.

“…Objective: to analyze the clinical and organizational feasibility of using different intervention thresholds for the Russian population.Subjects and methods…”
Get full text

Rheumatoid arthritis in real clinical practice: initiation of therapy with biological agents. Results of the «Computer Terminals of Self-Assessment for Patients with Rheumatic Diseases» («TERMINAL-II») project by Amirdzhanova, V. N., Pogozheva, E. Yu, Karateev, A. E., Antipova, O. V., Vinogradova, I. B., Kazankova, A. Yu, Mukhina, R. G., Vasilyev, A. G., Nesmeyanova, O. B., Bogdanova, E. A., Samigullina, R. R., Vasilenko, A. A., Bashkova, I. B., Salnikova, T. S., Dashkov, I. N., Nikulenkova, N. E., Manokhin, V. Yu, Afanasyeva, I. P., Anoshenkova, O. N., Plaksina, T. V., Spitsina, M. R., Solodovnikova, L. V., Petrov, A. V., Slyusar, O. P., Papichev, E. V., Ivanova, E. V., Masneva, L. V., Evstigneeva, L. P., Kolotilina, I. V., Otteva, E. N., Cherentsova, I. A., Shchendrygin, I. N., Derevenskikh, S. A., Bannikova, I. G., Delyavskaya, N. K., Danilova, I. N., Marusenko, I. M.

“…Objective: to assess quality-of-life (QoL) dynamics in patients with rheumatoid arthritis (RA) when initiating therapy with biological agents (BAs) in real…”
Get full text

Efficiency and safety of leflunomide in rheumatoid arthritis: Results of a Russian observational multicenter of trial by Balabanova, R. M., Dubinina, T. V., Goryachev, D. V., Anoshenkova, O. N., Antonova, E. A., Ilyevsky, I. Yu, Semagina, O. V., Yasyukevih, N. V.

“…Methotrexate or leflunomide is used as a first-line synthetic disease-modifying anti-rheumatic drug in the therapy of rheumatoid arthritis (RA). In 2011, the…”
Get full text

PREVALENCE AND RISK FACTORS OF LOW-ENERGY SKELETAL FRACTURES IN PATIENTS WITH CHRONIC INFLAMMATORY DISEASES. THE RESULTS OF A MULTICENTER STUDY OF THE RUSSIAN ASSOCIATION ON OSTEOPOROSIS GLUKOST by Baranova, I A, Ershova, O B, Anaev, E Kh, Anikhina, T N, Anoshenkova, O N, Batyn, S Z, Belyaeva, E A, Bolshakova, T Yu, Volkorezov, I A, Eliseeva, L N, Kashnazarova, E V, Kinyaykin, M F, Kirpikova, M N, Klyuchnikova, E P, Korolev, M A, Kuneevskaya, I V, Masneva, L V, Muradyants, A A, Otteva, E N, Petrachkova, T N, Peshekhonova, L K, Povzun, A S, Raskin, T A, Smirnova, M L, Toportsova, N V, Khasanova, R B, Shamsutdinova, N G, Shaporova, N L, Shitova, N S, Shkireeva, S Yu, Shostak, N A, Lesnyak, O M

“…Objectives. This study is a part of GLUKOST study hosted and organized by the Russian Association of Osteoporosis. The aim was to estimate the incidence and…”
Get full text

The influence of type 2 diabetes mellitus on clinical manifestations of osteoarthritis by E. A. Taskina, L. I. Alekseeva, N. G. Kashevarova, E. A. Strebkova, E. P. Sharapova, N. M. Savushkina, K. M. Mikhailov, T. A. Raskina, I. B. Vinogradova, E. N. Otteva, E. V. Zonova, O. N. Anoshenkova, A. M. Lila

“…Objective: to investigate in a multicenter study relationship between type 2 diabetes mellitus (DM) and clinical manifestations of osteoarthritis (OA)…”
Get full text

Switching from interleukin-6 receptor inhibitors to the direct interleukin-6 inhibitor olokizumab in patients with rheumatoid arthritis: efficacy and safety during one year of therapy by Shesternya, P. A., Baranov, A. A., Vinogradova, I. B., Anoshenkova, O. N., Antipova, O. V., Bogdanova, E. A., Grabovetskaya, Yu. Yu, Ilivanova, E. P., Kalyagin, A. N., Blinova, A. A., Lapkina, N. A., Mokrousova, M. V., Nesmeyanova, O. B., Nikitina, N. M., Yudina, N. V., Alekseev, E. N., Nasonov, E. L., Lila, A. M.

“…Objective : to investigate the efficacy and safety of olokizumab (OKZ) in patients with rheumatoid arthritis (RA) over a 12-month period after switching from…”
Get full text

Efficacy and safety of levilimab in the treatment of rheumatoid arthritis in real-life clinical practice: first results of the HELIOS observational study by A. M. Lila, I. Z. Gaydukova, O. N. Anoshenkova, I. G. Bannikova, I. B. Vinogradova, M. L. Goldman, S. Yu. Davidian, L. P. Evstigneeva, O. E. Epifanova, E. V. Zemerova, A. I. Zagrebneva, L. V. Ivanova, A. K. Karibova, I. V. Menshikova, O. N. Mironenko, M. P. Mikhailova, N. E. Nikulenkova, I. M. Patrikeeva, T. V. Plaksina, G. R. Savvina, R. R. Samigullina, L. E. Sarantseva, J. V. Usacheva, O. P. Ukhanova, G. F. Fatkhullina, A. L. Chudinov, I. A. Shafieva, S. P. Yakupova

“…The efficacy and safety of levilimab (LVL) in patients with active rheumatoid arthritis (RA) has been confirmed in controlled clinical trials. This article…”
Get full text